Comparison of low-dose rofecoxib versus 1000 mg naproxen in patients with osteoarthritis. Results of two randomized treatment trials of six weeks duration.
Myllykangas-Luosujärvi R, Lu HS, Chen SL, Choon D, Amante C, Chow CT, Pasero G, Genti G, Sarembock B, Zerbini CA, Vrijens F, Moan A, Rodgers DB, De Tora L, Laurenzi M; Naproxen 901 OF study group Naproxen 901 OC study group.
Myllykangas-Luosujärvi R, et al. Among authors: amante c.
Scand J Rheumatol. 2002;31(6):337-44. doi: 10.1080/030097402320817059.
Scand J Rheumatol. 2002.
PMID: 12492248
Clinical Trial.